Tevogen Bio Holdings Inc. has announced that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197). The application is titled "Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models" and covers technology developed by Tevogen.AI. This technology uses machine learning algorithms to rapidly and accurately identify peptides with strong immune system interactions, aiding in the development of targeted therapies for various diseases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.